A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus
Phase of Trial: Phase III
Latest Information Update: 08 Jan 2018
At a glance
- Drugs Insulin degludec/liraglutide (Primary) ; Insulin degludec; Liraglutide
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DUAL-I-Japan
- Sponsors Novo Nordisk
- 03 Jan 2018 Status changed from active, no longer recruiting to completed.
- 20 Dec 2017 Planned primary completion date changed from 25 Dec 2017 to 19 Dec 2017.
- 10 Jun 2017 Biomarkers information updated